These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 16897706

  • 21. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB, Kushnirov VV, Ter-Avanesian MD.
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [Abstract] [Full Text] [Related]

  • 22. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.
    Chaturvedi RK, Beal MF.
    Mol Cell Neurosci; 2013 Jul; 55():101-14. PubMed ID: 23220289
    [Abstract] [Full Text] [Related]

  • 23. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A, Bodis-Wollner I.
    Neurobiology (Bp); 1993 Jul; 1(2):101-22. PubMed ID: 8111350
    [Abstract] [Full Text] [Related]

  • 24. alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease.
    Witt SN, Flower TR.
    FEMS Yeast Res; 2006 Dec; 6(8):1107-16. PubMed ID: 17156009
    [Abstract] [Full Text] [Related]

  • 25. Yeast as a platform to explore polyglutamine toxicity and aggregation.
    Duennwald ML.
    Methods Mol Biol; 2013 Dec; 1017():153-61. PubMed ID: 23719914
    [Abstract] [Full Text] [Related]

  • 26. Protein folding diseases and neurodegeneration: lessons learned from yeast.
    Winderickx J, Delay C, De Vos A, Klinger H, Pellens K, Vanhelmont T, Van Leuven F, Zabrocki P.
    Biochim Biophys Acta; 2008 Jul; 1783(7):1381-95. PubMed ID: 18298958
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Coenzyme Q treatment of neurodegenerative diseases of aging.
    Galpern WR, Cudkowicz ME.
    Mitochondrion; 2007 Jun; 7 Suppl():S146-53. PubMed ID: 17485247
    [Abstract] [Full Text] [Related]

  • 29. Mitochondria and neurodegeneration.
    Petrozzi L, Ricci G, Giglioli NJ, Siciliano G, Mancuso M.
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [Abstract] [Full Text] [Related]

  • 30. Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease.
    Spires TL, Hannan AJ.
    J Neurochem; 2007 Feb; 100(4):874-82. PubMed ID: 17217424
    [Abstract] [Full Text] [Related]

  • 31. Yeast-Based Screens to Target Alpha-Synuclein Toxicity.
    Brás IC, Popova B, Braus GH, Outeiro TF.
    Methods Mol Biol; 2019 Feb; 1948():145-156. PubMed ID: 30771176
    [Abstract] [Full Text] [Related]

  • 32. Design and implementation of cell-based assays to model human disease.
    Jones JO, Diamond MI.
    ACS Chem Biol; 2007 Nov 20; 2(11):718-24. PubMed ID: 18030988
    [Abstract] [Full Text] [Related]

  • 33. Screening for genetic modifiers of amyloid toxicity in yeast.
    Giorgini F, Muchowski PJ.
    Methods Enzymol; 2006 Nov 20; 412():201-22. PubMed ID: 17046660
    [Abstract] [Full Text] [Related]

  • 34. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
    Fernández-Ruiz J, Romero J, Ramos JA.
    Handb Exp Pharmacol; 2015 Nov 20; 231():233-59. PubMed ID: 26408163
    [Abstract] [Full Text] [Related]

  • 35. Mechanisms of disease II: cellular protein quality control.
    Outeiro TF, Tetzlaff J.
    Semin Pediatr Neurol; 2007 Mar 20; 14(1):15-25. PubMed ID: 17331880
    [Abstract] [Full Text] [Related]

  • 36. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
    Wong HK, Bauer PO, Kurosawa M, Goswami A, Washizu C, Machida Y, Tosaki A, Yamada M, Knöpfel T, Nakamura T, Nukina N.
    Hum Mol Genet; 2008 Oct 15; 17(20):3223-35. PubMed ID: 18658163
    [Abstract] [Full Text] [Related]

  • 37. Drug discovery and development for Huntington's disease - an orphan indication with high medical need.
    Heitz F, La Rosa S, Gonzalez-Couto E, Gaviraghi G, Terstappen GC.
    IDrugs; 2008 Sep 15; 11(9):653-60. PubMed ID: 18763216
    [Abstract] [Full Text] [Related]

  • 38. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
    Mandel SA, Fishman T, Youdim MB.
    Parkinsonism Relat Disord; 2007 Sep 15; 13 Suppl 3():S242-7. PubMed ID: 18267243
    [Abstract] [Full Text] [Related]

  • 39. Recent developments in Parkinson's disease and Huntington's chorea.
    Barbeau A.
    Int J Neurol; 1976 Sep 15; 11(1):17-27. PubMed ID: 138661
    [No Abstract] [Full Text] [Related]

  • 40. Intrabody applications in neurological disorders: progress and future prospects.
    Miller TW, Messer A.
    Mol Ther; 2005 Sep 15; 12(3):394-401. PubMed ID: 15964243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.